NEW YORK (GenomeWeb News) – The Fairbanks Institute for Healthy Communities has tapped BioServe to process biological samples for a longitudinal study of coronary artery disease, the company said today.
The Indianapolis, Ind.-based institute will use BioServe’s sample processing services on samples for the Indiana Health Study, which plans to enlist thousands of participants from the Indianapolis region to create a research platform that will support the development of new drugs and diagnostics for chronic diseases including heart disease, cancer, and diabetes.
The study also will use the informatics capabilities of the Regenstrief Institute at Indiana University to study retrospective and prospective medical information.
BioServe said that the Indiana Health Study will integrate biological samples — such as serum, DNA, plasma, and RNA — along with medical data and lifestyle information from patients with coronary artery disease and people without the disease.
Financial terms of the agreement were not released.